|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. Feb 4–2021.(Online
ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Boda D, Neagu M, Constantin C, Voinescu
RN, Caruntu C, Zurac S, Spandidos DA, Drakoulis N, Tsoukalas D and
Tsatsakis AM: HPV strain distribution in patients with genital
warts in a female population sample. Oncol Lett. 12:1779–1782.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hoppe-Seyler K, Bossler F, Braun JA,
Herrmann AL and Hoppe-Seyler F: The HPV E6/E7 oncogenes: Key
factors for viral carcinogenesis and therapeutic targets. Trends
Microbiol. 26:158–168. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dardiotis E, Siokas V, Garas A,
Paraskevaidis E, Kyrgiou M, Xiromerisiou G, Deligeoroglou E,
Galazios G, Kontomanolis EN, Spandidos DA, et al: Genetic
variations in the SULF1 gene alter the risk of cervical cancer and
precancerous lesions. Oncol Lett. 16:3833–3841. 2018.PubMed/NCBI
|
|
5
|
Boda D, Docea AO, Calina D, Ilie MA,
Caruntu C, Zurac S, Neagu M, Constantin C, Branisteanu DE,
Voiculescu V, et al: Human papilloma virus: Apprehending the link
with carcinogenesis and unveiling new research avenues (Review).
Int J Oncol. 52:637–655. 2018.PubMed/NCBI
|
|
6
|
Li S, Hong X, Wei Z, Xie M, Li W, Liu G,
Guo H, Yang J, Wei W and Zhang S: Ubiquitination of the HPV
oncoprotein E6 is critical for E6/E6AP-mediated p53 degradation.
Front Microbiol. 10:24832019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Martinez-Zapien D, Ruiz FX, Poirson J,
Mitschler A, Ramirez J, Forster A, Cousido-Siah A, Masson M, Vande
Pol S, Podjarny A, et al: Structure of the E6/E6AP/p53 complex
required for HPV-mediated degradation of p53. Nature. 529:541–545.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Celegato M, Messa L, Goracci L, Mercorelli
B, Bertagnin C, Spyrakis F, Suarez I, Cousido-Siah A, Trave G,
Banks L, et al: A novel small-molecule inhibitor of the human
papillomavirus E6-p53 interaction that reactivates p53 function and
blocks cancer cells growth. Cancer Lett. 470:115–125. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ganti K, Massimi P, Manzo-Merino J, Tomaic
V, Pim D, Playford MP, Lizano M, Roberts S, Kranjec C, Doorbar J
and Banks L: Interaction of the human papillomavirus E6 oncoprotein
with sorting nexin 27 modulates endocytic cargo transport pathways.
PLoS Pathog. 12:e10058542016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hatterschide J, Bohidar AE, Grace M,
Nulton TJ, Kim HW, Windle B, Morgan IM, Munger K and White EA:
PTPN14 degradation by high-risk human papillomavirus E7 limits
keratinocyte differentiation and contributes to HPV-mediated
oncogenesis. Proc Natl Acad Sci USA. 116:7033–7042. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Barr JA, Hayes KE, Brownmiller T, Harold
AD, Jagannathan R, Lockman PR, Khan S and Martinez I: Long
non-coding RNA FAM83H-AS1 is regulated by human papillomavirus 16
E6 independently of p53 in cervical cancer cells. Sci Rep.
9:36622019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sharma S and Munger K: Expression of the
cervical carcinoma expressed PCNA regulatory (CCEPR) long noncoding
RNA is driven by the human papillomavirus E6 protein and modulates
cell proliferation independent of PCNA. Virology. 518:8–13. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
He H, Liu X, Liu Y, Zhang M, Lai Y, Hao Y,
Wang Q, Shi D, Wang N, Luo XG, et al: Human papillomavirus E6/E7
and long noncoding RNA TMPOP2 mutually upregulated gene expression
in cervical cancer cells. J Virol. 93:e01808–18. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dong J, Su M, Chang W, Zhang K, Wu S and
Xu T: Long non-coding RNAs on the stage of cervical cancer
(Review). Oncol Rep. 38:1923–1931. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sun NX, Ye C, Zhao Q, Zhang Q, Xu C, Wang
SB, Jin ZJ, Sun SH, Wang F and Li W: Long noncoding RNA-EBIC
promotes tumor cell invasion by binding to EZH2 and repressing
E-cadherin in cervical cancer. PLoS One. 9:e1003402014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jeong G, Bae H, Jeong D, Ham J, Park S,
Kim HW, Kang HS and Kim SJ: A Kelch domain-containing KLHDC7B and a
long non-coding RNA ST8SIA6-AS1 act oppositely on breast cancer
cell proliferation via the interferon signaling pathway. Sci Rep.
8:129222018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Martin-Pardillos A and Cajal SRY:
Characterization of Kelch domain-containing protein 7B in breast
tumours and breast cancer cell lines. Oncol Lett. 18:2853–2860.
2019.PubMed/NCBI
|
|
18
|
Beltrán-Anaya FO, Romero-Córdoba S,
Rebollar-Vega R, Arrieta O, Bautista-Piña V, Dominguez-Reyes C,
Villegas-Carlos F, Tenorio-Torres A, Alfaro-Riuz L, Jiménez-Morales
S, et al: Expression of long non-coding RNA ENSG00000226738
(LncKLHDC7B) is enriched in the immunomodulatory triple-negative
breast cancer subtype and its alteration promotes cell migration,
invasion, and resistance to cell death. Mol Oncol. 13:909–927.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guo P, Wang D, Wu J, Yang J, Ren T, Zhu B
and Xiang Y: The landscape of alternative splicing in cervical
squamous cell carcinoma. Onco Targets Ther. 8:73–79.
2015.PubMed/NCBI
|
|
20
|
Wu X, Zheng X, Cheng J, Zhang K and Ma C:
LncRNA TUG1 regulates proliferation and apoptosis by regulating
miR-148b/IGF2 axis in ox-LDL-stimulated VSMC and HUVEC. Life Sci.
243:1172872020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kuhn RM, Haussler D and Kent WJ: The UCSC
genome browser and associated tools. Brief Bioinform. 14:144–161.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mishra GP, Ghosh A, Jha A and Raghav SK:
BedSect: An integrated web server application to perform
intersection, visualization, and functional annotation of genomic
regions from multiple datasets. Front Genet. 11:32020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu Y, Chen X, Cheng R, Yang F, Yu M, Wang
C, Cui S, Hong Y, Liang H, Liu M, et al: The Jun/miR-22/HuR
regulatory axis contributes to tumourigenesis in colorectal cancer.
Mol Cancer. 17:112018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li Z, Zhao Z, Cai Z, Sun Y, Li L, Yao F,
Yang L, Zhou Y, Zhu H, Fu Y, et al: Runx2 (Runt-related
transcription factor 2)-mediated microcalcification is a novel
pathological characteristic and potential mediator of abdominal
aortic aneurysm. Arterioscler Thromb Vasc Biol. 40:1352–1369. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tian S, Zhang L, Li Y, Cao D, Quan S, Guo
Y, Yang X and Yang T: Human papillomavirus E7 oncoprotein promotes
proliferation and migration through the transcription factor E2F1
in cervical cancer cells. Anticancer Agents Med Chem. Nov
5–2020.(Epub ahead of print). View Article : Google Scholar
|
|
26
|
Santegoets LA, Seters M, Helmerhorst TJ,
Heijmans-Antonissen C, Hanifi-Moghaddam P, Ewing PC, van Ijcken WF,
van der Spek PJ, van der Meijden WI and Blok LJ: HPV related VIN:
Highly proliferative and diminished responsiveness to extracellular
signals. Int J Cancer. 121:759–766. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Integrated genomic and molecular
characterization of cervical cancer. Nature. 543:378–384. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mao Y, Dong L, Zheng Y, Dong J and Li X:
Prediction of Recurrence in Cervical Cancer Using a Nine-lncRNA
Signature. Front Genet. 10:2842019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hosseini ES, Meryet-Figuiere M,
Sabzalipoor H, Kashani HH, Nikzad H and Asemi Z: Dysregulated
expression of long noncoding RNAs in gynecologic cancers. Mol
Cancer. 16:1072017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Feng S, Liu W, Bai X, Pan W, Jia Z, Zhang
S, Zhu Y and Tan W: LncRNA-CTS promotes metastasis and
epithelial-to-mesenchymal transition through regulating
miR-505/ZEB2 axis in cervical cancer. Cancer Lett. 465:105–117.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ding X, Jia X, Wang C, Xu J, Gao SJ and Lu
C: A DHX9-lncRNA-MDM2 interaction regulates cell invasion and
angiogenesis of cervical cancer. Cell Death Differ. 26:1750–1765.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wu X, Xiao Y, Yan W, Ji Z and Zheng G: The
human oncogene SCL/TAL1 interrupting locus (STIL) promotes tumor
growth through MAPK/ERK, PI3K/Akt and AMPK pathways in prostate
cancer. Gene. 686:220–227. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang G, Fan E, Yue G, Zhong Q, Shuai Y,
Wu M, Feng G, Chen Q and Gou X: Five genes as a novel signature for
predicting the prognosis of patients with laryngeal cancer. J Cell
Biochem. Oct 31–2019.(Epub ahead of print).
|
|
34
|
Westrich JA, Warren CJ, Klausner MJ, Guo
K, Liu CW, Santiago ML and Pyeon D: Human papillomavirus 16 E7
stabilizes APOBEC3A protein by inhibiting cullin 2-dependent
protein degradation. J Virol. 92:e01318–17. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Panayiotou T, Michael S, Zaravinos A,
Demirag E, Achilleos C and Strati K: Human papillomavirus E7 binds
Oct4 and regulates its activity in HPV-associated cervical cancers.
PLoS Pathog. 16:e10084682020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sanda T, Lawton LN, Barrasa MI, Fan ZP,
Kohlhammer H, Gutierrez A, Ma W, Tatarek J, Ahn Y, Kelliher MA, et
al: Core transcriptional regulatory circuit controlled by the TAL1
complex in human T cell acute lymphoblastic leukemia. Cancer Cell.
22:209–221. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mansour MR, Sanda T, Lawton LN, Li X,
Kreslavsky T, Novina CD, Brand M, Gutierrez A, Kelliher MA,
Jamieson CH, et al: The TAL1 complex targets the FBXW7 tumor
suppressor by activating miR-223 in human T cell acute
lymphoblastic leukemia. J Exp Med. 210:1545–1557. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ngoc PCT, Tan SH, Tan TK, Chan MM, Li Z,
Yeoh AEJ, Tenen DG and Sanda T: Identification of novel lncRNAs
regulated by the TAL1 complex in T-cell acute lymphoblastic
leukemia. Leukemia. 32:2138–2151. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Vasseur D, Lopez J, Croce S, Tondeur G,
Bonin L, Descotes F, Golfier F and Devouassoux-Shisheboran M:
Transcriptome profiling of gastric-type endocervical
adenocarcinomas identifies key signaling pathways for tumor
progression. Gynecol Oncol. 157:775–782. 2020. View Article : Google Scholar : PubMed/NCBI
|
